HealthEquity Basic EPS 2014-2025 | HQY
HealthEquity annual/quarterly basic eps history and growth rate from 2014 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- HealthEquity basic eps for the quarter ending January 31, 2025 was $0.30, a 3.23% decline year-over-year.
- HealthEquity basic eps for the twelve months ending January 31, 2025 was $1.11, a 70.77% increase year-over-year.
- HealthEquity annual basic eps for 2025 was $0.001B, a 70.77% increase from 2024.
- HealthEquity annual basic eps for 2024 was $0.001B, a 309.68% decline from 2023.
- HealthEquity annual basic eps for 2023 was $-0B, a 41.51% decline from 2022.
| HealthEquity Annual Basic EPS | |
|---|---|
| 2025 | $1.11 |
| 2024 | $0.65 |
| 2023 | $-0.31 |
| 2022 | $-0.53 |
| 2021 | $0.12 |
| 2020 | $0.59 |
| 2019 | $1.20 |
| 2018 | $0.79 |
| 2017 | $0.45 |
| 2016 | $0.29 |
| 2015 | $0.39 |
| 2014 | $-1.26 |
| 2013 | $0.81 |
| HealthEquity Quarterly Basic EPS | |
|---|---|
| 2025-01-31 | $0.30 |
| 2024-10-31 | $0.07 |
| 2024-07-31 | $0.41 |
| 2024-04-30 | $0.33 |
| 2024-01-31 | $0.31 |
| 2023-10-31 | $0.17 |
| 2023-07-31 | $0.12 |
| 2023-04-30 | $0.05 |
| 2023-01-31 | |
| 2022-10-31 | $-0.02 |
| 2022-07-31 | $-0.13 |
| 2022-04-30 | $-0.16 |
| 2022-01-31 | $-0.39 |
| 2021-10-31 | $-0.06 |
| 2021-07-31 | $-0.05 |
| 2021-04-30 | $-0.03 |
| 2021-01-31 | $0.07 |
| 2020-10-31 | $0.02 |
| 2020-07-31 | $0.00 |
| 2020-04-30 | $0.03 |
| 2020-01-31 | $-0.08 |
| 2019-10-31 | $-0.30 |
| 2019-07-31 | $0.30 |
| 2019-04-30 | $0.67 |
| 2019-01-31 | $0.22 |
| 2018-10-31 | $0.25 |
| 2018-07-31 | $0.36 |
| 2018-04-30 | $0.37 |
| 2018-01-31 | $0.11 |
| 2017-10-31 | $0.17 |
| 2017-07-31 | $0.28 |
| 2017-04-30 | $0.23 |
| 2017-01-31 | $0.07 |
| 2016-10-31 | $0.10 |
| 2016-07-31 | $0.14 |
| 2016-04-30 | $0.14 |
| 2016-01-31 | $0.05 |
| 2015-10-31 | $0.07 |
| 2015-07-31 | $0.08 |
| 2015-04-30 | $0.09 |
| 2015-01-31 | $-0.38 |
| 2014-10-31 | $0.06 |
| 2014-07-31 | $0.19 |
| 2014-04-30 | $0.52 |
| 2014-01-31 | |
| 2013-10-31 | $0.11 |
| 2013-07-31 | $0.12 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.042B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.512B | 27.48 |
| Elevance Health (ELV) | United States | $86.065B | 11.11 |
| CVS Health (CVS) | United States | $83.137B | 10.33 |
| Cencora (COR) | United States | $55.558B | 19.33 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.771B | 0.00 |
| BioMerieux (BMXMF) | France | $16.981B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.266B | 0.00 |
| Solventum (SOLV) | United States | $12.874B | 13.63 |
| ICON (ICLR) | Ireland | $11.753B | 10.93 |
| CochLear (CHEOY) | Australia | $11.492B | 0.00 |
| Revvity (RVTY) | United States | $11.324B | 19.49 |
| Doximity (DOCS) | United States | $10.794B | 49.97 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Avantor (AVTR) | United States | $9.213B | 13.39 |
| Medpace Holdings (MEDP) | United States | $8.689B | 23.08 |
| Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.422B | 14.54 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.425B | 26.06 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 35.31 |
| Sotera Health (SHC) | United States | $3.423B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.055B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Concentras Parent (CON) | United States | $2.811B | 16.24 |
| Organon (OGN) | United States | $2.620B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.006B | 77.28 |
| Ardent Health (ARDT) | United States | $1.908B | 8.13 |
| Progyny (PGNY) | United States | $1.859B | 40.92 |
| Premier (PINC) | United States | $1.853B | 14.06 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.302B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.29 |
| CareDx (CDNA) | United States | $1.118B | 17.46 |
| Establishment Labs Holdings (ESTA) | $1.114B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.844B | 7.90 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.671B | 10.16 |
| Embecta (EMBC) | United States | $0.591B | 3.98 |
| LifeMD (LFMD) | United States | $0.574B | 0.00 |
| Enhabit (EHAB) | United States | $0.519B | 42.71 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.255B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.252B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.109B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| OpGen (OPGN) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |